NCT05283993View on ClinicalTrials.gov

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Multiple MyelomaAmyloidosisCryoglobulinemiaCastleman's DiseaseLight Chain Deposition DiseaseHeavy Chain Deposition DiseasePolyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin ChangesSmoldering Multiple MyelomaPlasma Cell LeukemiaMonoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Renal Significance (MGRS)Monoclonal Gammopathy of Neurological Significance (MGNS)
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER